Anti-MUC1 Nanobody Can Redirect T-Body Cytotoxic Effector Function-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-MUC1 Nanobody Can Redirect T-Body Cytotoxic Effector Function

Published:2009-04 Issue:2 Volume:28 Page:85-92
ISSN:1554-0014
Container-title:Hybridoma
language:en
Short-container-title:Hybridoma

Author:

Bakhtiari Seyed Hamid Aghaee¹,Rahbarizadeh Fatemeh¹,Hasannia Sadegh²,Ahmadvand Davoud³,Iri-Sofla Farnoush Jafari¹,Rasaee Mohammad Javad¹³

Affiliation:

1. Department of Medical Biotechnology, School of Medical Sciences, Tarbiat Modares University, Tehran, I.R. Iran.

2. Department of Biology, School of Basic Sciences, Guilan University, Rasht, I.R. Iran.

3. Department of Clinical Biochemistry, School of Medical Sciences, Tarbiat Modares University, Tehran, I.R. Iran.

Publisher

Mary Ann Liebert Inc

Subject

Immunology,Immunology and Allergy

Link

http://www.liebertpub.com/doi/pdf/10.1089/hyb.2008.0079

Reference32 articles.

1. Vaccine and antibody-directed T cell tumour immunotherapy

2. Supernatural T cells: genetic modification of T cells for cancer therapy

3. The T-Body Approach: Redirecting T Cells with Antibody Specificity

4. Single domain antibodies: comparison of camel VH and camelised human VH domains

5. Single domain camel antibodies: current status

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in the Utilization of Nanobody CAR-T Cell in Cancer Immunotherapy;Journal of Biomedical Nanotechnology;2024-08-01

2. Screening and anti‐glioma activity of Chiloscyllium plagiosum anti‐human IL‐13Rα2 single‐domain antibody;Immunology;2023-05-15

3. New cell sources for CAR-based immunotherapy;Biomarker Research;2023-05-06

4. Application of nanotechnology in CAR-T-cell immunotherapy;Chinese Chemical Letters;2023-03

5. Nanobodies in cell-mediated immunotherapy: On the road to fight cancer;Frontiers in Immunology;2023-01-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3